Dual delivery of an antibiotic and a growth factor addresses both the microbiological and biological challenges of contaminated bone fractures.
about
The potential role of regenerative medicine in the man-agement of traumatic patients.Vancomycin-bearing synthetic bone graft delivers rhBMP-2 and promotes healing of critical rat femoral segmental defects.D-amino acid inhibits biofilm but not new bone formation in an ovine model.Tunable staged release of therapeutics from layer-by-layer coatings with clay interlayer barrier.Design and development of reactive injectable and settable polymeric biomaterials.Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering.Stimuli-responsive polymers for antimicrobial therapy: drug targeting, contact-killing surfaces and competitive release.Bacteria and osteoblast adhesion to chitosan immobilized titanium surface: A race for the surface.Inhibition of fracture healing in the presence of contamination by Staphylococcus aureus: Effects of growth state and immune response.Porous titanium scaffolds with self-assembled micro/nano hierarchical structure for dual functions of bone regeneration and anti-infection.Rifamycin Derivatives Are Effective Against Staphylococcal Biofilms In Vitro and Elutable From PMMA.Effect of coadministration of vancomycin and BMP-2 on cocultured Staphylococcus aureus and W-20-17 mouse bone marrow stromal cells in vitro.Tetracycline-encapsulated P(3HB) microsphere-coated 45S5 Bioglass(®)-based scaffolds for bone tissue engineering.Testing of a bioactive, moldable bone graft substitute in an infected, critically sized segmental defect model.Composite chitosan and calcium sulfate scaffold for dual delivery of vancomycin and recombinant human bone morphogenetic protein-2.
P2860
Q34884800-2DE976DB-5043-4C74-BE5B-8DC218713915Q35426027-C66056B7-7C3A-4103-852C-839983C3B98EQ36226100-0C330D2A-043B-4667-9913-0750C1927AFCQ37633656-17A358B7-3822-459F-97D9-D02B024CAB4DQ38105523-082EB20E-D84C-4BF7-84D8-88B476734D16Q38115348-B53351EA-8335-4265-9205-D2CF7DBCBC94Q38807442-AE920C69-5B14-469D-98A9-BCF6AD8924BDQ38848201-731DFF30-1324-4F4C-84D7-16191841516CQ39226629-5F74E266-B8E2-4DA9-96C0-A78842000D71Q40104471-74B8C219-7405-42B6-BAD9-D3D5A607B5CFQ41304306-65C3D5F1-E4A9-410A-A877-E534A1821152Q42036354-086A0CF3-D39F-4C95-BF8A-7CBA771B7141Q43625784-24DB3405-D6E0-48EA-9BDE-834F4BF38BC0Q47659722-ECE7A1EB-EE79-4C53-9901-3A78512BF9E3Q53624920-080F30E7-5453-4143-A813-31F4E36D8496
P2860
Dual delivery of an antibiotic and a growth factor addresses both the microbiological and biological challenges of contaminated bone fractures.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dual delivery of an antibiotic ...... f contaminated bone fractures.
@en
Dual delivery of an antibiotic ...... f contaminated bone fractures.
@nl
type
label
Dual delivery of an antibiotic ...... f contaminated bone fractures.
@en
Dual delivery of an antibiotic ...... f contaminated bone fractures.
@nl
prefLabel
Dual delivery of an antibiotic ...... f contaminated bone fractures.
@en
Dual delivery of an antibiotic ...... f contaminated bone fractures.
@nl
P2860
P1476
Dual delivery of an antibiotic ...... f contaminated bone fractures.
@en
P2093
Joseph C Wenke
Scott A Guelcher
P2860
P304
P356
10.1517/17425247.2011.628655
P407
P577
2011-10-22T00:00:00Z